Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection

Dumoutier, 2000, Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, J Immunol, 164, 1814, 10.4049/jimmunol.164.4.1814 Dumoutier, 2000, Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor, Proc Natl Acad Sci USA, 97, 10144, 10.1073/pnas.170291697 Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, J Biol Chem, 275, 31335, 10.1074/jbc.M005304200 Wolk, 2006, Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells, Cytokine Growth Factor Rev, 17, 367, 10.1016/j.cytogfr.2006.09.001 Savan, 2009, Structural conservation of interferon gamma among vertebrates, Cytokine Growth Factor Rev, 20, 115, 10.1016/j.cytogfr.2009.02.006 Pestka, 2004, Interleukin-10 and related cytokines and receptors, Annu Rev Immunol, 22, 929, 10.1146/annurev.immunol.22.012703.104622 Nagem, 2002, Crystal structure of recombinant human interleukin-22, Structure (Camb), 10, 1051, 10.1016/S0969-2126(02)00797-9 de Oliveira Neto, 2008, Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains, Biophys J, 94, 1754, 10.1529/biophysj.107.112664 Xu, 2004, Crystallization and X-ray diffraction analysis of insect-cell-derived IL-22, Acta Crystallogr D Biol Crystallogr, 60, 1295, 10.1107/S0907444904010492 Logsdon, 2004, The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation, J Mol Biol, 342, 503, 10.1016/j.jmb.2004.07.069 Langer, 2004, The Class II cytokine receptor (CRF2) family: overview and patterns of receptor–ligand interactions, Cytokine Growth Factor Rev, 15, 33, 10.1016/j.cytogfr.2003.10.001 Kotenko, 2001, Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes, J Biol Chem, 276, 2725, 10.1074/jbc.M007837200 Sabat, 2007, IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases, Expert Opin Ther Targets, 11, 601, 10.1517/14728222.11.5.601 Logsdon, 2002, Comparison of interleukin-22 and interleukin-10 soluble receptor complexes, J Interferon Cytokine Res, 22, 1099, 10.1089/10799900260442520 Li, 2004, Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2, Int Immunopharmacol, 4, 693, 10.1016/j.intimp.2004.01.010 Wolk, 2005, Is there an interaction between interleukin-10 and interleukin-22?, Genes Immun, 6, 8, 10.1038/sj.gene.6364144 Reineke, 1999, Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope, J Mol Recognit, 12, 242, 10.1002/(SICI)1099-1352(199907/08)12:4<242::AID-JMR461>3.0.CO;2-1 Gough, 2008, IFNgamma signaling-does it mean JAK-STAT?, Cytokine Growth Factor Rev, 19, 383, 10.1016/j.cytogfr.2008.08.004 Lejeune, 2002, Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, J Biol Chem, 277, 33676, 10.1074/jbc.M204204200 Dumoutier, 2009, New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain, J Biol Chem, 284, 26377, 10.1074/jbc.M109.007955 Wolk, 2002, Cutting edge: immune cells as sources and targets of the IL-10 family members?, J Immunol, 168, 5397, 10.4049/jimmunol.168.11.5397 Wolk, 2008, Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes, J Leukoc Biol, 83, 1181, 10.1189/jlb.0807525 Wolk, 2006, IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis, Eur J Immunol, 36, 1309, 10.1002/eji.200535503 Chung, 2006, Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes, Cell Res, 16, 902, 10.1038/sj.cr.7310106 Duhen, 2009, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nat Immunol, 10, 857, 10.1038/ni.1767 Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J Exp Med, 203, 2271, 10.1084/jem.20061308 Trifari, 2009, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells, Nat Immunol, 10, 864, 10.1038/ni.1770 Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, 445, 648, 10.1038/nature05505 Billiau, 2009, Interferon-gamma: a historical perspective, Cytokine Growth Factor Rev, 20, 97, 10.1016/j.cytogfr.2009.02.004 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Brustle, 2007, The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4, Nat Immunol, 8, 958, 10.1038/ni1500 Crome, 2009, The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells, Eur J Immunol, 39, 1480, 10.1002/eji.200838908 Ivanov, 2006, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 Mangan, 2006, Transforming growth factor-beta induces development of the T(H)17 lineage, Nature, 441, 231, 10.1038/nature04754 Spolski, 2009, Cytokine mediators of Th17 function, Eur J Immunol, 39, 658, 10.1002/eji.200839066 Veldhoen, 2006, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001 Yang, 2008, T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma, Immunity, 28, 29, 10.1016/j.immuni.2007.11.016 Blanco, 2008, Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine Growth Factor Rev, 19, 41, 10.1016/j.cytogfr.2007.10.004 Fitzgerald-Bocarsly, 2008, Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history, Cytokine Growth Factor Rev, 19, 3, 10.1016/j.cytogfr.2007.10.006 Liu, 2009, Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans, Eur J Immunol, 39, 1472, 10.1002/eji.200838811 Volpe, 2008, A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses, Nat Immunol, 9, 650, 10.1038/ni.1613 Manel, 2008, The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat, Nat Immunol, 9, 641, 10.1038/ni.1610 Stockinger, 2009, Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor—the role of endogenous ligands, Eur J Immunol, 39, 652, 10.1002/eji.200839134 Veldhoen, 2009, Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells, J Exp Med, 206, 43, 10.1084/jem.20081438 Veldhoen, 2008, The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins, Nature, 453, 106, 10.1038/nature06881 Alam, 2010, Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor, Proc Natl Acad Sci USA, 107, 5943, 10.1073/pnas.0911755107 Ciric, 2009, IL-23 drives pathogenic IL-17-producing CD8+ T cells, J Immunol, 182, 5296, 10.4049/jimmunol.0900036 Hamada, 2009, Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge, J Immunol, 182, 3469, 10.4049/jimmunol.0801814 Martin, 2009, Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals, Immunity, 31, 321, 10.1016/j.immuni.2009.06.020 Sutton, 2009, Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity, Immunity, 31, 331, 10.1016/j.immuni.2009.08.001 Monteleone, 2009, Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease, Cytokine Growth Factor Rev, 20, 185, 10.1016/j.cytogfr.2009.02.002 Dhiman, 2009, IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion, J Immunol, 183, 6639, 10.4049/jimmunol.0902587 Cella, 2009, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity, Nature, 457, 722, 10.1038/nature07537 Luci, 2009, Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin, Nat Immunol, 10, 75, 10.1038/ni.1681 Sanos, 2009, RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells, Nat Immunol, 10, 83, 10.1038/ni.1684 Satoh-Takayama, 2009, The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium, J Immunol, 183, 6579, 10.4049/jimmunol.0901935 Satoh-Takayama, 2008, Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense, Immunity, 29, 958, 10.1016/j.immuni.2008.11.001 Hughes, 2009, Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22, Blood, 113, 4008, 10.1182/blood-2008-12-192443 Cupedo, 2009, Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells, Nat Immunol, 10, 66, 10.1038/ni.1668 Marchesi, 2009, CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles, Mucosal Immunol, 2, 486, 10.1038/mi.2009.113 Crellin, 2010, Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells, J Exp Med, 207, 281, 10.1084/jem.20091509 Takatori, 2009, Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22, J Exp Med, 206, 35, 10.1084/jem.20072713 Goto, 2009, Murine NKT cells produce Th17 cytokine interleukin-22, Cell Immunol, 254, 81, 10.1016/j.cellimm.2008.10.002 Wahl, 2009, IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency, J Immunol, 182, 4521, 10.4049/jimmunol.0802810 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Weber, 2007, Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis, Infect Immun, 75, 1690, 10.1128/IAI.01564-06 Aujla, 2008, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, Nat Med, 14, 275, 10.1038/nm1710 Siegemund, 2009, Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis, Int Immunol, 21, 555, 10.1093/intimm/dxp025 Raffatellu, 2009, Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine, Cell Host Microbe, 5, 476, 10.1016/j.chom.2009.03.011 Wang, 2009, Fibroblastic colony-forming unit bone marrow cells delay progression to gastric dysplasia in a helicobacter model of gastric tumorigenesis, Stem Cells, 27, 2301, 10.1002/stem.165 Zheng, 2008, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat Med, 14, 282, 10.1038/nm1720 Buonocore, 2010, Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology, Nature, 464, 1371, 10.1038/nature08949 Brand, 2007, IL-22 mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro, Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00239.2006 De Luca A, Zelante T, D’Angelo C, Zagarella S, Fallarino F, Spreca A, et al., IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. May 5. Munoz, 2009, Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17, J Exp Med, 206, 3047, 10.1084/jem.20090900 Scriba, 2008, Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response, J Immunol, 180, 1962, 10.4049/jimmunol.180.3.1962 Arias, 2010, High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses, Retrovirology, 7, 15, 10.1186/1742-4690-7-15 Bingold, 2010, Interleukin-22 Detected In Patients With Abdominal Sepsis, Shock, 10.1097/SHK.0b013e3181dc07b1 Dambacher, 2008, The role of interleukin-22 in hepatitis C virus infection, Cytokine, 41, 209, 10.1016/j.cyto.2007.11.016 Pan, 2004, Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3, Cell Mol Immunol, 1, 43 Ma, 2008, IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation, J Clin Invest, 118, 597 Andoh, 2005, Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts, Gastroenterology, 129, 969, 10.1053/j.gastro.2005.06.071 Wolk, 2007, IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease, J Immunol, 178, 5973, 10.4049/jimmunol.178.9.5973 Sugimoto, 2008, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis, J Clin Invest, 118, 534 Zenewicz, 2007, Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation, Immunity, 27, 647, 10.1016/j.immuni.2007.07.023 Ikeuchi, 2005, Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine, Arthritis Rheum, 52, 1037, 10.1002/art.20965 Kebir, 2007, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651 Kreymborg, 2007, IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis, J Immunol, 179, 8098, 10.4049/jimmunol.179.12.8098 Chang, 2006, Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats, J Immunol, 177, 3635, 10.4049/jimmunol.177.6.3635 Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J Immunol, 174, 3695, 10.4049/jimmunol.174.6.3695 Lecart, 2002, IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells, Int Immunol, 14, 1351, 10.1093/intimm/dxf096 Aggarwal, 2001, Acinar cells of the pancreas are a target of interleukin-22, J Interferon Cytokine Res, 21, 1047, 10.1089/107999001317205178 Brand, 2006, IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration, Am J Physiol Gastrointest Liver Physiol, 290, G827, 10.1152/ajpgi.00513.2005 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, J Mol Med, 87, 523, 10.1007/s00109-009-0457-0 Nagalakshmi, 2004, Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells, Int Immunopharmacol, 4, 679, 10.1016/j.intimp.2004.01.008 Whittington, 2004, Interleukin-22: a potential immunomodulatory molecule in the lung, Am J Respir Cell Mol Biol, 31, 220, 10.1165/rcmb.2003-0285OC Dumoutier, 2001, Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22, J Immunol, 166, 7090, 10.4049/jimmunol.166.12.7090 Gruenberg, 2001, A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta, Genes Immun, 2, 329, 10.1038/sj.gene.6363786 Kotenko, 2001, Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity, J Immunol, 166, 7096, 10.4049/jimmunol.166.12.7096 Xu, 2001, A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist, Proc Natl Acad Sci USA, 98, 9511, 10.1073/pnas.171303198 Wei, 2003, Cloning and characterization of mouse IL-22 binding protein, Genes Immun, 4, 204, 10.1038/sj.gene.6363947 Weiss, 2004, Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart, Genes Immun, 5, 330, 10.1038/sj.gene.6364104 Jones, 2008, Structure of IL-22 bound to its high-affinity IL-22R1 chain, Structure, 16, 1333, 10.1016/j.str.2008.06.005 de Moura, 2009, Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22, FEBS Lett, 583, 1072, 10.1016/j.febslet.2009.03.006 Dumoutier, 2001, Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types, J Immunol, 167, 3545, 10.4049/jimmunol.167.7.3545 Wilson, 2010, Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections, J Immunol, 184, 4378, 10.4049/jimmunol.0903416 Harder, 2005, Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins, J Leukoc Biol, 77, 476, 10.1189/jlb.0704409 Sa, 2007, The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis, J Immunol, 178, 2229, 10.4049/jimmunol.178.4.2229 Wolk, 2009, The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis, Eur J Immunol, 39, 3570, 10.1002/eji.200939687 Blumberg, 2001, Interleukin 20: discovery, receptor identification, and role in epidermal function, Cell, 104, 9, 10.1016/S0092-8674(01)00187-8 Radaeva, 2004, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 39, 1332, 10.1002/hep.20184 Schulz, 2008, Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17, J Immunol, 181, 7891, 10.4049/jimmunol.181.11.7891 Shioya, 2008, Interleukin 22 receptor 1 expression in pancreas islets, Pancreas, 36, 197, 10.1097/MPA.0b013e3181594258 Heilmann, 2009, Osteopontin as two-sided mediator of intestinal inflammation, J Cell Mol Med, 13, 1162, 10.1111/j.1582-4934.2008.00428.x Sodek, 2006, Osteopontin and mucosal protection, J Dent Res, 85, 404, 10.1177/154405910608500503 Wang, 2008, Osteopontin: role in immune regulation and stress responses, Cytokine Growth Factor Rev, 19, 333, 10.1016/j.cytogfr.2008.08.001 Fiedler, 1998, Acute-phase response of the rat pancreas protects against further aggression with severe necrotizing pancreatitis, Crit Care Med, 26, 887, 10.1097/00003246-199805000-00024 Gironella, 2005, Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease, Gut, 54, 1244, 10.1136/gut.2004.056309 Heller, 1999, Pancreatitis-associated protein protects the lung from leukocyte-induced injury, Anesthesiology, 91, 1408, 10.1097/00000542-199911000-00034 Sekikawa, 2010, Involvement of the IL-22/REG Ialpha axis in ulcerative colitis, Lab Invest, 90, 496, 10.1038/labinvest.2009.147 Glaser, 2005, Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection, Nat Immunol, 6, 57, 10.1038/ni1142 Holmes, 2005, Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration, Structure, 13, 29, 10.1016/j.str.2004.10.009 Sohnle, 2000, Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14), J Infect Dis, 182, 1272, 10.1086/315810 Michalek, 2009, The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes, Dev Comp Immunol, 33, 740, 10.1016/j.dci.2008.12.005 Cash, 2006, Symbiotic bacteria direct expression of an intestinal bactericidal lectin, Science, 313, 1126, 10.1126/science.1127119 Liang, 2007, An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment, J Immunol, 179, 7791, 10.4049/jimmunol.179.11.7791 Lin, 2009, Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis, Immunity, 31, 799, 10.1016/j.immuni.2009.08.025 Yao, 2010, Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis, PLoS Pathog, 6, e1000789, 10.1371/journal.ppat.1000789 Misse, 2007, IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction, J Immunol, 178, 407, 10.4049/jimmunol.178.1.407 Pagliaccetti, 2010, Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities, Virology, 401, 197, 10.1016/j.virol.2010.02.022 Hennig, 2007, Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection, Liver Int, 27, 1134, 10.1111/j.1478-3231.2007.01518.x Levillayer, 2007, Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases, Genetics, 176, 1835, 10.1534/genetics.107.073536 Genin, 2009, The role of differential expression of human interferon—a genes in antiviral immunity, Cytokine Growth Factor Rev, 20, 283, 10.1016/j.cytogfr.2009.07.005 Witte, 2010, IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties, Cytokine Growth Factor Rev, 21, 237, 10.1016/j.cytogfr.2010.04.002 Feng, 2005, Human beta-defensins: differential activity against candidal species and regulation by Candida albicans, J Dent Res, 84, 445, 10.1177/154405910508400509 Murthy, 1993, In vitro candidastatic properties of the human neutrophil calprotectin complex, J Immunol, 151, 6291, 10.4049/jimmunol.151.11.6291 Conti, 2009, Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis, J Exp Med, 206, 299, 10.1084/jem.20081463 Kisand, 2010, Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines, J Exp Med, 207, 299, 10.1084/jem.20091669 Pitta, 2009, IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani, J Clin Invest, 119, 2379 Bromberg, 1999, Stat3 as an oncogene, Cell, 98, 295, 10.1016/S0092-8674(00)81959-5 Chan, 2008, Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis, Oncogene, 27, 1087, 10.1038/sj.onc.1210726 Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L. Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control. Mar 26. Nagakawa, 2004, Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts, Scand J Immunol, 60, 449, 10.1111/j.0300-9475.2004.01504.x Weber, 2006, IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase, J Immunol, 177, 8266, 10.4049/jimmunol.177.11.8266 Zhang, 2008, Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts, Clin Cancer Res, 14, 6432, 10.1158/1078-0432.CCR-07-4401 Bard, 2008, Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma, Leukemia, 22, 1595, 10.1038/leu.2008.129 Guttman-Yassky, 2008, Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis, J Immunol, 181, 7420, 10.4049/jimmunol.181.10.7420 Nograles, 2009, IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells, J Allergy Clin Immunol, 123, 10.1016/j.jaci.2009.03.041 Pickert, 2009, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing, J Exp Med, 206, 1465, 10.1084/jem.20082683 Zenewicz, 2008, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease, Immunity, 29, 947, 10.1016/j.immuni.2008.11.003 Geboes, 2009, Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice, Arthritis Rheum, 60, 390, 10.1002/art.24220 Gangemi, 2010, Is interleukin-22 a possible indicator of chronic heart failure's progression?, Arch Gerontol Geriatr, 50, 311, 10.1016/j.archger.2009.05.003 Cheng, 2009, Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus, Ann Rheum Dis, 68, 604, 10.1136/ard.2008.097089 Pan, 2009, Decreased serum IL-22 levels in patients with systemic lupus erythematosus, Clin Chim Acta, 401, 179, 10.1016/j.cca.2008.11.009 Larsen, 2009, IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis, J Allergy Clin Immunol, 123, 486, 10.1016/j.jaci.2008.09.036 Zhao, 2010, Th17 immunity in patients with allergic asthma, Int Arch Allergy Immunol, 151, 297, 10.1159/000250438 Schnyder, 2010, Interleukin-22 is a negative regulator of the allergic response, Cytokine, 50, 220, 10.1016/j.cyto.2010.02.003 Endam, 2009, Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis, Otolaryngol Head Neck Surg, 140, 741, 10.1016/j.otohns.2008.12.058 Smith, 2009, Cytokine and cytokine receptor gene polymorphisms and their functionality, Cytokine Growth Factor Rev, 20, 43, 10.1016/j.cytogfr.2008.11.006 Ramanathan, 2007, Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor, Laryngoscope, 117, 1839, 10.1097/MLG.0b013e31811edd4f